Skip to product information
1 of 1
HPLC-Verified > 99%

CJC-1295 / Ipamorelin

CJC-1295 / Ipamorelin

Lyophilized Peptide • Research Grade
Regular price $79.00 USD
Regular price Sale price $79.00 USD
Sale Sold out
Quantity

Certificate of Analysis

Third Party Tested

TLDR

TL;DR:

A combination GHRH analog plus GHSR-1a agonist used to study synergistic GH-axis signaling and pituitary secretagogue pathways.

Description

Product Description
Lyophilized dual-analogue blend of a GHRH analog (CJC-1295) and a selective GHSR-1a agonist (Ipamorelin) for synergistic GH-axis research.

Key Research Mechanism
GHRH-receptor activation plus ghrelin-receptor agonism is used to examine complementary secretagogue pathways and combined GH/IGF-1 output in experimental systems.

Primary Research Areas

  • Dual GH-secretagogue signaling
  • Pituitary receptor pharmacology
  • IGF-1 pathway assays

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.

Shipping & Returns

Orders placed by 3PM will ship same day. All orders placed after 3PM will ship next business day.

Injectables are Non-returnable items
Certain types of items cannot be returned, like perishable goods (such as food, flowers, or plants), custom products (such as special orders or personalized items), and personal care goods (such as beauty products, supplements, and injectables). We also do not accept returns for hazardous materials, flammable liquids, or gases.

Please get in touch if you have questions or concerns about the quality of your specific item and we will work on resolution.

View full details

Certificate of Analysis

Third Party Tested

Molecular Profile

A combination GHRH analog plus GHSR-1a agonist used to study synergistic GH-axis signaling and pituitary secretagogue pathways.

Compound CJC-1295 / Ipamorelin
Batch # N/A
Formula C38H49N9O5
Mol Wt 711.9 g/mol
CAS 170851-70-4
latest ISO 17025 8× Testing

99.63%

Purity
VariantCJC-1295 / Ipamorelin
COA ##13140
Labeled5mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
Purity (HPLC) - 99.63%
Net Peptide Content - 5mg
Identity (HPLC) - Ipamorelin
Fentanyl Screen - Not Detected
HPLC Conformity mean - >99%
ISO/IEC 17025 Accredited
Storage Requirements

Stability Information

Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder) −20°C long-term
2–8°C
Reconstituted Recommended condition
Light protection Store away from light

Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.

Certificate of Analysis

Precision Synthesis

Developed in collaboration with leading US-based scientific facilities to push the boundaries of biochemical research.

Explore Research Blog

Safety & Regulatory Compliance Warning

These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.